In this issue:
Prostate bed salvage radiotherapy + ADT and PLN treatment
Persistently elevated PSA after salvage lymph node dissection
Blood-based test to support biopsy decision-making
PSA kinetics and predictive nomograms for salvage radiotherapy
Biomarkers of clinical outcomes in mHSPC
Local treatment of metastatic prostate cancer
Standardised uptake on PSMA PET/CT and oncological outcomes
MRI and targeted biopsies in recurrent prostate cancer after radiotherapy
Obesity impact on outcomes after RARP
Previous negative biopsies and rates of progression during AS
Please login below to download this issue (PDF)